2-Methyl-2-(4-nitro-1H-imidazol-1-yl)propan-1-ol, 98%, 25g

Ethyl 3-methylpiperidine-3-carboxylate hydrochloride, 95.0%, 1g

5-Bromo-N1-methylbenzene-1,2-diamine, 95.0%, 50g

DIETHYL ISOPROPENYL PHOSPHATE, 95%, 25g

2-BROMO-1,3-DIFLUORO-4-METHOXYBENZENE, 95%, 1g

Trifluoroacetic acid, sodium salt, 98.0%, 10g

2-Amino-4-(4'-bromophenyl)-1,3-thiazole, 97.0%, 25g

Microliter syringe GASTIGHT® series 1700 Point type 3, 25 µl, 1702 RNR, 1 piece

4-(4-Nitrophenyl)butan-2-ol, 97%, 250mg

TERT-BUTYL (2-CHLORO-3-IODOPYRIDIN-4-YL)CARBAMATE, 95.0%, 5g

N1-((Ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine, 98.0%, 5g

2-Anthramine, 98%, 250mg

(S)-1-(Thiophen-3-yl)ethan-1-amine, 97%, 100mg